Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Endocr Disord ; 23(1): 195, 2023 Sep 12.
Article in English | MEDLINE | ID: mdl-37700304

ABSTRACT

BACKGROUND: To investigate the prevalence of euthyroid sick syndrome (ESS) and to evaluate the outcomes and risk factors associated with ESS among hospitalized patients with diabetic ketosis (DK) or diabetic ketoacidosis (DKA). METHODS: Laboratory and clinical data of 396 adult hospitalized DK/DKA patients with or without ESS were collected and analyzed. Spearman linear analysis and multivariable logistic regression analyses were used to evaluate correlated factors of thyroid hormones and risk factors of ESS. RESULTS: Most of the individuals were diagnosed with type 2 diabetes (359/396, 90.7%). The prevalence of ESS was 57.8% (229/396). Patients in ESS group were older and had a longer course of diabetes. Levels of thyroid hormones, serum lipids, and parameters reflecting acidosis were significantly decreased in ESS group. The proportion of patients with infection, acute renal injury and DKA was significantly higher in ESS group than in control group, accompanied by longer hospitalization stay and higher hospitalization costs. Free triiodothyronine positively correlates with albumin, eGFR, parameters reflecting acidosis and lipid profiles (All P < 0.001), and negatively correlates with age, onset age, 24-h urine albumin, hsCRP and WBC count (All P < 0.001). Hypoalbuminemia, low level of carbon dioxide combining power, high level of HbA1c and WBC, and co-infection are shown to be risk factors for ESS (OR = 0.866, 0.933, 1.112, 1.146, 1.929, respectively; All P < 0.05). CONCLUSIONS: The prevalence of ESS was high in adult DK/DKA patients. Patients with ESS had inferior clinical and socioeconomic outcomes. Early recognition and management of patients with ESS may be necessary to improve outcome.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Ketoacidosis , Euthyroid Sick Syndromes , Ketosis , Adult , Humans , Young Adult , Diabetic Ketoacidosis/epidemiology , Diabetic Ketoacidosis/etiology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/epidemiology , Prevalence , Euthyroid Sick Syndromes/epidemiology , Risk Factors , Hospitalization , Albumins
2.
Int J Biol Macromol ; 236: 124001, 2023 May 01.
Article in English | MEDLINE | ID: mdl-36907308

ABSTRACT

This study aimed to explore whether Dendrobium huoshanense stem polysaccharide (cDHPS) ameliorates alcohol-induced gastric ulcer (GU) through the strengthening effect of the gastric mucosal barrier in rats and its potential mechanism. In normal rats, the pretreatment of cDHPS effectively strengthened gastric mucosal barrier by increasing mucus secretion and tight junction protein expression. In GU rats, cDHPS supplementation effectively alleviated alcohol-induced gastric mucosal injury and nuclear factor κB (NF-κB)-driven inflammation by strengthening gastric mucosal barrier. Moreover, cDHPS significantly activated nuclear factor E2-related factor 2 (Nrf2) signaling and promoted antioxidant enzymes activities in both normal and GU rats. These results suggested that the pretreatment of cDHPS could strengthen gastric mucosal barrier to inhibit oxidative stress and NF-κB-driven inflammation induced gastric mucosal injury, which was likely related to the activation of Nrf2 signaling.


Subject(s)
Dendrobium , Stomach Ulcer , Rats , Animals , NF-kappa B/metabolism , Stomach Ulcer/chemically induced , Stomach Ulcer/drug therapy , Stomach Ulcer/metabolism , NF-E2-Related Factor 2/metabolism , Antioxidants/pharmacology , Inflammation , Polysaccharides/adverse effects
3.
Carbohydr Polym ; 206: 149-162, 2019 Feb 15.
Article in English | MEDLINE | ID: mdl-30553308

ABSTRACT

The present study investigated the effects of a homogeneous Dendrobium huoshanense polysaccharide (GXG) on mucosal barrier function and microbiota composition in different intestinal regions of mice. Results exhibited, besides changing the intestinal physiological status, orally administrated GXG could improve the intestinal physical barrier function by modulating mucosal structures and up-regulating the expression of tight junction proteins, reinforce the intestinal biochemical barrier function by elevating the expression and secretion of mucin-2, ß-defensins and sIgA, and regulate the intestinal immunological barrier function by stimulating the production of cytokines and the functional development of immune cells. Simultaneously, GXG could differentially impact the composition and metabolism of microbiota along intestinal tract. In addition, the immune response in spleen and peripheral blood were effectively regulated by GXG. These results indicated that GXG might be used as functional agent to improve host health.


Subject(s)
Dendrobium/chemistry , Gastrointestinal Microbiome/drug effects , Intestinal Mucosa/drug effects , Intestines/drug effects , Polysaccharides/pharmacology , Acids, Acyclic/metabolism , Administration, Oral , Animals , Blood/drug effects , Blood/immunology , Cytokines/metabolism , Female , Intestinal Mucosa/immunology , Intestines/physiology , Mice, Inbred C57BL , Polysaccharides/administration & dosage , Polysaccharides/isolation & purification , Prebiotics , Spleen/drug effects , Spleen/immunology
SELECTION OF CITATIONS
SEARCH DETAIL